Breaking News

Glooko, Sanofi Partner for SoloStar Pen Connectivity with New Device SoloSmart

The alliance will allow for visualization of the data in the Glooko app, that patients can share with healthcare professionals.

Glooko Inc., has partnered with Sanofi to increase their support of people living with diabetes and healthcare professionals, by integrating SoloSmart with the Glooko platform. SoloSmart is a single piece add-on connected device intended for use with SoloStar and DoubleStar insulin injection pens which records the insulin dose, date and time of injection. It also allows for visualization of the data in the Glooko app, that patients can share with healthcare professionals for connected care...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters